What is the CVR number of HyperBio Therapeutics ApS?

HyperBio Therapeutics ApS is registered with CVR / Virk under CVR 41244909.

What is the revenue of HyperBio Therapeutics ApS?

HyperBio Therapeutics ApS reported revenue of DKK -74K in 2023.

How many employees does HyperBio Therapeutics ApS have?

HyperBio Therapeutics ApS employs 1 people as of the latest annual report.

Who is the CEO of HyperBio Therapeutics ApS?

Søren Sylvester Skjærbæk is Management of HyperBio Therapeutics ApS, in role since 2020.

Who is the chairman of HyperBio Therapeutics ApS?

Morten Døssing chairs the board of HyperBio Therapeutics ApS, in role since 2020.

Where is HyperBio Therapeutics ApS headquartered?

HyperBio Therapeutics ApS's registered address is Stærmosevej 12.

HyperBio Therapeutics ApS

APSIn liquidation

CVR 41244909Stærmosevej 12Research and experimental development on natural sciences and engineering · NACE 7210Est. 20201 employees

Full Risika report

Revenue 2023

DKK -74K

-99% vs 2022

EBITDA margin

100.0%

+99% vs 2022

Equity ratio

5.0%

Financial strength

Net profit 2023

DKK -973K

+87% vs 2022

EBITDA — year on yearDKK millions

Key figuresAnnual report 2023

Revenue	DKK -74K	-99%
EBITDA	DKK -74K	+99%
Net profit	DKK -973K	+87%
Total assets	DKK 14,7M	-6%
Equity	DKK 740K	+132%
Employees	1	—

Item	2020	2021	2022	2023
Revenue	-5.571	-12.882	-8.629	-74
Staff expenses	-40	-60	-55	-0
EBITDA	-5.611	-12.942	-8.684	-74
Depreciation & amort.	-0	-0	-0	-0
EBIT	-5.611	-12.942	-8.684	-74
Net financials	-20	-479	-1.322	-1.176
Profit before tax	-5.632	-13.421	-10.006	-1.250
Tax	-1.573	-2.808	-2.349	-277
Net profit	-4.058	-10.613	-7.656	-973

Item	2020	2021	2022	2023
Total assets	12.036	22.827	15.672	14.654
Equity	10.982	5.369	-2.287	740
Long-term debt	0	15.355	0	0
Short-term debt	1.054	2.103	17.959	13.914
Total debt	1.054	17.458	17.959	13.914

Name	Role	Member since	Age	Other directorships
SS Søren Sylvester Skjærbæk Management	Management	2020	—	—

Name	Role	Member since	Age	Other directorships
MD Morten Døssing	Chairman	2020	—	—
NB Niccolo' Bacchi-Bønnelykke	Board of Directors	2020	—	—

Shareholder	Type	Ownership	Votes	Since
Novo Holdings A/S	Company	100.0%	100.0%	2020

Person	Role here	Other companies
Søren Sylvester Skjærbæk	Management	0 companies
Morten Døssing	Chairman	0 companies
Niccolo' Bacchi-Bønnelykke	Board of Directors	0 companies